NPR/The federal government has reached a deal worth up to $2.1 billion with drugmakers Sanofi and GlaxoSmithKline as part of Operation Warp Speed, the Trump administration’s push to have a coronavirus vaccine widely available by early 2021.

The money will go toward clinical trials, scaling up manufacturing and purchasing 100 million doses of the vaccine.

This is the sixth vaccine candidate to join Operation Warp Speed’s portfolio, and the largest vaccine deal to date. The federal government has also made deals with AstraZeneca, Johnson & Johnson, Moderna, Novavax and Pfizer.

More at NPR





Comments are closed.

 

 


hey